Skip to main content

February 2024

 

 

academics

 

Clinical research courses

JAMP group Inviting proficient Pharmacovigilance experts

The JAMP group is a proud Canadian owned company with its international headquarters located in Boucherville, 20 minutes from downtown Montreal, Quebec, Canada. The JAMP Pharma Group is active in all sectors of the pharmaceutical industry with our JAMP Pharma Generics, Orimed branded products, our Wampole and Laboratoire Suisse natural health supplements and our Cosmetic Import beauty and personal care products. The JAMP Pharma Group has also made a major investment in biosimilars which is one of the fastest growing markets in the pharmaceutical industry.

Interview for B.Pharm, M.Pharm in QA, QC, Regulatory Affairs, F&D at Bharat Parenterals

Bharat Parenterals Ltd. is a Gujarat based pharmaceutical company, established in 1992 by Mr. Ramesh Desai, who started the company with a vision of making world class affordable medicines and to take it to the forefront of contract manufacturing units in Gujarat.

Work as Research Assistant at Universiti Malaya, MSc, B.Pharm Apply

Universiti Malaya, or UM, Malaysia's oldest university, is situated on a 922 acre (373.12 hectare) campus in the southwest of Kuala Lumpur, the capital of Malaysia.  It was founded on 28 September 1905 in Singapore as the King Edward VII College of Medicine and  on 8th October 1949, it became the Universiti Malaya with  the merger of the King Edward VII College of Medicine and Raffles College (founded in 1928).

Post : Graduate Research Assistant

NIHR awards 7m Euro to the University of Birmingham to provide strategic leadership for its Research Support Service

The NIHR has selected the University of Birmingham to run the National Collaborative for its Research Support Service (RSS) from 1 February 2024.

The RSS was launched on 1 October 2023. The service provides expert research design, methodological support, advice, and collaboration to all researchers in England throughout the pre- and post-application/research process, regardless of geographic location and research interest.

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

BioNTech SE a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, and Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced a strategic collaboration aimed at advancing both companies’ autologous CAR-T programs towards commercialization, pending regulatory authorizations. In connection with the strategic collaboration, the companies entered into a license and option agreement and a securities purchase agreement.

Bristol Myers Squibb announces acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy

Bristol Myers Squibb announced two regulatory acceptances for applications for neoadjuvant Opdivo (nivolumab) with chemotherapy followed by surgery and adjuvant Opdivo for the perioperative treatment of resectable stage IIA to IIIB non-small cell lung cancer (NSCLC). The U.S. Food and Drug Administration (FDA) accepted the supplemental Biologics Application (sBLA) and assigned a Prescription Drug User Fee Act (PDUFA) goal date of October 8, 2024.

AI model as diabetes early warning system when driving

Low blood sugar levels (hypoglycemia) are one of the most dangerous complications of diabetes and pose high risk during cognitively demanding tasks requiring complex motor skills, such as driving a car. The utility of current tools to detect hypoglycemia is limited by diagnostic delay, invasiveness, low availability, and high costs. A recent study published in the journal NEJM AI provides a novel way to detect hypoglycemia during driving.

Scientists develop a low-cost device to make cell therapy safer

A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.

Vacancy for M.Pharm, B.Pharm as Senior Manager / Manager at Alembic Pharma

Alembic Pharmaceuticals Limited, with its world class facilities for manufacturing parenteral / injectable products has urgent openings for its Panelav site near Vadodara. The site is designed for state-of-the-art aseptic operations and isolator technologies.

Post : Senior Manager / Manager

Job Openings for Pharmacists under Regional Director of Medical and Health Services, 20 Openings

Applications are invited from eligible candidates for the post of Pharmacist Gr.II in health institutions of Zone-II under the control of the Regional Director of Medical & Health Services, Zone-II on Contract basis.

Post : Pharmacist Grade -II